Uppsala, Sweden - The risk of bladder cancer rises steadily with increasing cumulative dose of cyclophosphamide in patients with Wegener's granulomatosis (WG), although some of this risk is ...
Cyclophosphamide is a widely used alkylating agent that requires metabolic conversion to exert its antineoplastic effects. As a prodrug, it undergoes hepatic bioactivation predominantly via cytochrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results